Newsletter | May 23, 2023

05.23.23 -- Multiple Myeloma: Using The Immune System For Better Patient Outcomes

Featured Editorial
Industry Insights
Best Practices For Sterile Fill Operator Gowning Training

Sterile fill operators are crucial in ensuring pharmaceutical products are contaminant-free and safe for use. Explore best practices for sterile fill operator gowning training, mobile cleanroom benefits, and more.

How To Adapt Efficiently To A New Era Of Supply Chain Manufacturing

It’s no secret – COVID-19 changed things. Now, as the pharma supply chain settles into a new normal, executives are shifting focus to better identify reliable, resilient, and forward-thinking partners.

Matters Of Scale: Centralized Vs. Decentralized Manufacturing Of Advanced Therapies

Reducing human intervention and manual processes in advanced therapy manufacturing is critical to improving a manufacturing paradigm, safeguarding quality, simplifying processes, and improving efficacy.

Enhancing Lentiviral And AAV Transduction Of T Cells

Learn about new data that highlights exciting uses for future immunotherapy studies.

High Throughput AAV Viral Titering Using Nanoplate-Based Digital PCR

Nano-plate-based dPCR is compared to ddPCR analyses for different types of AAV samples to demonstrate that the QIAcuity is a successful platform for AAV titering.

Viral Vector Commercialization – Part 1: Technology Transfer Processes

Developing and manufacturing viral vectors at scale requires scientific expertise, technological know-how, and a solid infrastructure — all facilitated by a successful tech transfer process.

Innovations In Cell And Gene Therapy Manufacturing For 2023 And Beyond

From supply chain constraints to siloed data to characterization and development hurdles, the variables that can limit scale for advanced therapies are both diverse and profound.

In Silico In Action: A Case Study In Relapsing Remitting Multiple Sclerosis

Discover how in silico recreation can be a valuable tool for predicting the efficacy of new treatments.

Large-Scale AAV Manufacturing: From Concept To Ready-To-Use Platform

Surmounting challenges related to AAV manufacturing and scale-up represent an important opportunity for the advanced therapeutics space; finding the right partner hinges on experience, expertise, and capacity.

Delivering Flexibility Without Complexity

Next generation drug products are more targeted and patient specific by nature causing batch sizes to be much smaller. This paradigm shift paves the way for more flexible manufacturing solutions.

Ensuring Expectations Of Quality Are Met In Plasmid DNA Manufacture

Examine the benefits of considering quality attributes early in the drug lifecycle and how an experienced CDMO can offer flexible, comprehensive support along the full development to commercialization journey.

Assurance Of Clonality For Biotherapeutics

The clonality of Master Cell Banks (MCBs) for production cell lines is a key requirement in biotherapeutics manufacturing. Learn how new devices help optimize the cloning process.

Oligonucleotide Development And Manufacturing Workflow

Learn more about oligo workflows and solutions for oligonucleotide process development, from scalable oligo synthesis to cleavage and deprotection, purification, and buffer exchange.

Overcoming Commercialization Challenges For Cell & Gene Therapies

This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps and strategies and solutions to facilitate development through commercialization.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.